SREBF2
Basic information
Region (hg38): 22:41833105-41907306
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia (Limited), mode of inheritance: AR
- multiple congenital anomalies/dysmorphic syndrome (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (149 variants)
- not_provided (17 variants)
- SREBF2-related_disorder (16 variants)
- Hypercholesterolemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SREBF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004599.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | |||||
missense | 147 | 156 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 148 | 16 | 7 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SREBF2 | protein_coding | protein_coding | ENST00000361204 | 19 | 74204 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.207 | 0.793 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.679 | 605 | 654 | 0.925 | 0.0000427 | 7310 |
Missense in Polyphen | 180 | 225.29 | 0.79899 | 2486 | ||
Synonymous | -0.178 | 275 | 271 | 1.01 | 0.0000177 | 2405 |
Loss of Function | 5.05 | 12 | 50.9 | 0.236 | 0.00000280 | 531 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000331 | 0.000329 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000133 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000357 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator required for lipid homeostasis. Regulates transcription of the LDL receptor gene as well as the cholesterol and to a lesser degree the fatty acid synthesis pathway (By similarity). Binds the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3') found in the flanking region of the LDRL and HMG-CoA synthase genes. {ECO:0000250}.;
- Pathway
- Sterol Regulatory Element-Binding Proteins (SREBP) signalling;SREBF and miR33 in cholesterol and lipid homeostasis;Angiopoietin Like Protein 8 Regulatory Pathway;Metabolism of lipids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Metabolism;Metabolism of steroids;srebp control of lipid synthesis;Activation of gene expression by SREBF (SREBP)
(Consensus)
Recessive Scores
- pRec
- 0.474
Intolerance Scores
- loftool
- 0.357
- rvis_EVS
- -1.83
- rvis_percentile_EVS
- 2.09
Haploinsufficiency Scores
- pHI
- 0.660
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Srebf2
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- srebf2
- Affected structure
- liver
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;lipid metabolic process;cholesterol metabolic process;cellular response to starvation;positive regulation of cholesterol storage;cholesterol homeostasis;regulation of cholesterol biosynthetic process;positive regulation of transcription by RNA polymerase II;cellular response to low-density lipoprotein particle stimulus;cellular response to laminar fluid shear stress;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of cholesterol efflux;positive regulation of pri-miRNA transcription by RNA polymerase II;regulation of autophagy of mitochondrion;positive regulation of protein targeting to mitochondrion
- Cellular component
- Golgi membrane;nucleus;nucleoplasm;cytoplasm;mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;ER to Golgi transport vesicle membrane;SREBP-SCAP-Insig complex;intracellular membrane-bounded organelle
- Molecular function
- C-8 sterol isomerase activity;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;protein C-terminus binding;protein dimerization activity;E-box binding